Peer-reviewedCC BY-NC-NDJournal of thoracic disease
Examined lymph node count and survival in resected non-small cell lung cancer: attenuation of benefit beyond 16 nodes is confined to node-negative disease
Related
- Number of examined lymph nodes and overall survival in intrahepatic cholangiocarcinoma: a population-based study suggesting a staging benefit
- Clinical and pathological characteristics, immune microenvironment, and survival analysis of molecular subtypes of surgically resected small cell lung cancer.
- Case Report: Prolonged survival following multimodal treatment of leptomeningeal metastases in triple-negative glycogen-rich clear cell breast carcinoma
- Apparent Survival Benefit of Postoperative Radioactive Iodine in Lymph Node-Positive Papillary Thyroid Carcinoma: A Negative-Control Analysis for Unmeasured Confounding.
- Functional Status, Quality of Life and Survival After Repeated Intrathecal Administration of Autologous Lineage-Negative Cells in Amyotrophic Lateral Sclerosis
BibTeX
@article{anon2026examined,
title = {{Examined lymph node count and survival in resected non-small cell lung cancer: attenuation of benefit beyond 16 nodes is confined to node-negative disease}},
journal = {Journal of thoracic disease},
year = {2026},
month = sep,
url = {https://europepmc.org/article/PMC/PMC13655844},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - Examined lymph node count and survival in resected non-small cell lung cancer: attenuation of benefit beyond 16 nodes is confined to node-negative disease
PY - 2026
DA - 2026/09/23
JO - Journal of thoracic disease
UR - https://europepmc.org/article/PMC/PMC13655844
SN - 2072-1439
SN - 2077-6624
ER -